Bain Capital Life Sciences Fund, L.P.

13D and 13G Filings

13D/G filings
13G on 4 securities
Location
Boston, MA
CIK
0001687968
Form D filings
1 filing
All SEC filings
View on sec.gov
Issuer % of Class Filed
Rapid Micro Biosystems, Inc. 13G/A Amendment 1
RPID · 75340L104
16.8% 8/14/2026
Event 6/30/2026
Pharvaris N.V. 13G/A Amendment 4
PHVS · N69605108
2.5% 2/17/2026
Event 12/31/2025
X4 Pharmaceuticals, Inc. 13G/A Amendment 1
XFOR · 98420X202
7.4% 2/17/2026
Event 12/31/2025
Pharvaris N.V. 13G/A Amendment 3
PHVS · N69605108
3.0% 11/14/2025
Event 9/30/2025
X4 Pharmaceuticals, Inc. 13G
XFOR · 98420X202
10.0% 9/15/2025
Event 9/9/2025
X4 Pharmaceuticals, Inc. 13D
XFOR · 98420X202
10.0% 8/13/2025
Event 8/11/2025
Annexon, Inc. 13G/A Amendment 5
ANNX · 03589W102
4.9% 2/14/2025
Event 12/31/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.